Fujian Highton Development (603162.SH) forecasts a net profit of 478 million to 584 million yuan for 2024, an increase of 158.38% to 215.68% year-on-year.
Haitong Development (603162.SH) announced that the company is expected to achieve net profit attributable to shareholders of the parent company in 2024...
Fujian Highton Development (603162.SH) announced that the company is expected to achieve a net profit attributable to the owners of the parent company of 4.78 billion to 5.84 billion in 2024. This represents an increase of 2.93 billion to 3.99 billion compared to the same period last year (legally disclosed data), an increase of 158.38% to 215.68% year-on-year.
In 2024, the global economy is moderately recovering, overall trade demand is increasing. At the same time, with the tension in the Red Sea and conflicts between Russia and Ukraine, the global shipping market is showing signs of recovery, with dry bulk freight rates moving up. Faced with the complex domestic and international situations and the volatile market environment, the company is adapting to market trends by timely expanding its controlled capacity, optimizing global route layout, improving operational efficiency, reducing operating costs through refined management, and strengthening its own profit-making ability.
Related Articles

HK Stock Market Move | JINGCHENG MAC (00187) increased by over 5%, affiliated with Beijing Bawei to support the world's first tower-type solar thermal replacement project for ultra-heavy oil extraction being put into operation.

Innovative drug blockbuster! Arvinas (ARVN.US) collaborates with Pfizer Inc. (PFE.US) to advance the third-party commercialization of "breast cancer ER degrader."

BOCOM INTL: Slight differences between domestic and foreign capital in the industry fluctuations, seizing the opportunity to layout the undervalued high-quality assets in the innovative pharmaceutical industry chain.
HK Stock Market Move | JINGCHENG MAC (00187) increased by over 5%, affiliated with Beijing Bawei to support the world's first tower-type solar thermal replacement project for ultra-heavy oil extraction being put into operation.

Innovative drug blockbuster! Arvinas (ARVN.US) collaborates with Pfizer Inc. (PFE.US) to advance the third-party commercialization of "breast cancer ER degrader."

BOCOM INTL: Slight differences between domestic and foreign capital in the industry fluctuations, seizing the opportunity to layout the undervalued high-quality assets in the innovative pharmaceutical industry chain.
